Ozempic Semaglutide Injection Price and What It Actually Covers

The licence question that changes everything about price

Ozempic and Wegovy are both semaglutide injections made by Novo Nordisk, but they carry different UK licences. Ozempic is approved by the MHRA for type 2 diabetes management. Wegovy (at the 2.4 mg maintenance dose) holds a separate UK licence for weight management in adults with a BMI of 30 or above, or from 27 with a weight-related health condition. A prescriber cannot lawfully issue Ozempic for weight loss; if someone is offering it that way, that is a clinical and regulatory problem, not a pricing opportunity.

This matters to your price search because the product you are actually looking for (if weight loss is your goal) is Wegovy. You can read a full breakdown of how Wegovy injection pricing works in practice. The MHRA's public guidance on GLP-1 medicines for weight loss sets out the licensing picture clearly, and it is worth reading before you commit to any provider.

One quick check that takes under a minute: look up any online pharmacy you are considering on the GPhC pharmacy register. If it is not listed, it cannot legally dispense prescription medicines to UK patients. That single search filters out the majority of unsafe sellers.

What a quoted semaglutide price often leaves out

Private weight-loss treatment pricing in the UK is not standardised. Some providers quote a per-pen figure; others quote monthly; others bundle doses in ways that obscure what you are actually paying per week of treatment. What those headline numbers frequently exclude is worth spelling out.

Consultation fees are sometimes charged separately, a meaningful addition if you need dose reviews every four weeks. Prescription charges may appear at checkout. Delivery costs, particularly for a cold-chain medicine that needs next-day tracked shipping, add up over a year of treatment. And aftercare (access to a clinician when you have a question at 7pm on a Saturday) is rarely mentioned in the initial price but matters a great deal once you are on treatment.

The full cost of Wegovy is worth examining with all of those line items in mind. The Eli Lilly list-price increase in September 2025 (for tirzepatide) shifted the broader private-market context too, as providers across the sector recalculated their margins, something the international price comparison for Wegovy illustrates starkly.

Where nume sits on price, and why

Cheapest is not the race we entered. One transparent price from nume covers the consultation, the prescription written by a named clinician, the medicine itself, and free next-working-day tracked delivery by DPD in plain packaging. There is no subscription and no auto-renewal; every repeat is reviewed before it goes out. Current treatment pricing is shown on the treatment page, and there are no extra fees to discover at checkout.

Our prescribers (you can read about our clinical team on the clinical team page) review every consultation personally. A small saving on a monthly fee is not the right metric when the medicine requires ongoing clinical oversight to stay safe and effective. That is a straightforward position, and we are upfront about it.

For context on what the Ozempic injection pricing question really points to in a weight-loss context, that page sets out the licensing distinction in more detail alongside what a legitimate private semaglutide prescription actually involves.

Why 'cheapest' is the wrong test for a prescription semaglutide injection

The MHRA has seized approximately 20 million doses of illegally traded weight-loss medicines (worth around £45 million) and in October 2025 raided the first illicit UK site producing counterfeit tirzepatide pens. Counterfeit semaglutide pens have also been identified and in some cases contained insulin, leading to hospitalisations. If you want to understand how much semaglutide is in Ozempic, that page explains the dose composition in detail, which is useful context when assessing whether a product you are being offered is what it claims to be. Sellers offering semaglutide injections without requiring a prescription, or promoting prices far below the private market norm, are the pattern to avoid. The MHRA's Yellow Card scheme allows you to report suspected unsafe sellers directly.

A legitimate supply chain for a prescription semaglutide injection involves a licensed UK pharmacy, a GPhC-registered prescriber, and medicines sourced through authorised UK distributor routes. None of that infrastructure is free to run, which is why genuinely safe pricing has a floor. If a figure looks too far below market, the question to ask is what has been cut to get there. Our guidance on how much semaglutide injection to take explains the dose escalation schedule a responsible prescriber follows, which also helps illustrate why clinical oversight throughout treatment is not optional.

If you are ready to explore clinically supervised weight management with licensed treatment, our weight-loss treatment overview explains what that looks like from a UK clinical perspective, and the FAQs page covers the questions our prescribers hear most often.